Dr. Scott Newsome specializes in the care of patients with neuroimmunological and neuroinflammatory disorders of the central nervous system. He has special interest in evaluating and treating patients with multiple sclerosis, transverse myelitis, neuromyelitis optica, and stiff person syndrome. Dr. Newsome works within the division of Neuroimmunology and Neuroinfectious diseases at Johns Hopkins Hospital. He joined the Johns Hopkins Multiple Sclerosis and Transverse Myelitis centers after completing fellowship and he is currently the director of the Johns Hopkins Infusion Center and Stiff Person Syndrome Center and Co-Director of the Multiple Sclerosis Experimental Therapeutics Program.
Dr. Newsome received his medical degree from the New York College of Osteopathic Medicine and graduated with honors. He then completed his internship in internal medicine and residency in neurology at Albany Medical Center. During Dr. Newsome’s neurology residency, he was awarded the Golden Apple Outstanding Resident Teaching Award and later was chosen to be chief resident. He subsequently went on to complete a fellowship in neuroimmunology at The Johns Hopkins Hospital with the support of a Sylvia Lawry Physician Fellowship from the National Multiple Sclerosis Society.
Dr. Newsome’s main research focuses on helping identify and test novel therapies and therapeutic strategies in multiple sclerosis and other neuroimmunological disorders. In addition, other research endeavors include validating the use of new quantitative clinical outcome measures and imaging techniques in multiple sclerosis and identifying risk factors of disease onset and severity, response to treatment and long-term outcomes in neuroimmunological disorders. Currently, Dr. Newsome is involved in several clinical trials for multiple sclerosis, transverse myelitis, and neuromyelitis optica. He is also serving as treasurer of the Consortium of Multiple Sclerosis Centers, is an advisor for the National Multiple Sclerosis Society Clinical Advisory Committee, and a member of the Miller-Coulson Academy of Clinical Excellence.